Leen Mathys
Leuven, VLG 3000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Tryptophan dendrimers that inhibit HIV replication, prevent virus entry and bind to the HIV envelope glycoproteins gp120 and gp41.
Journal: European journal of medicinal chemistry
Published: July 31, 2015
The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition.
Journal: PloS one
Published: July 22, 2015
The role of cellular oxidoreductases in viral entry and virus infection-associated oxidative stress: potential therapeutic applications.
Journal: Expert opinion on therapeutic targets
Published: July 17, 2015
Anti-HIV-1 activity of a tripodal receptor that recognizes mannose oligomers.
Journal: European journal of medicinal chemistry
Published: January 22, 2015
The role of N-glycans of HIV-1 gp41 in virus infectivity and susceptibility to the suppressive effects of carbohydrate-binding agents.
Journal: Retrovirology
Published: May 28, 2014
Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity.
Journal: PloS one
Published: April 28, 2014
Exposure of HIV-1 to a combination of two carbohydrate-binding agents markedly delays drug resistance development and selects for virus strains with compromised fitness.
Journal: The Journal of antimicrobial chemotherapy
Published: October 23, 2013
Inhibition of infection and transmission of HIV-1 and lack of significant impact on the vaginal commensal lactobacilli by carbohydrate-binding agents.
Journal: The Journal of antimicrobial chemotherapy
Published: May 04, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026